Morteza Akbari

975 total citations
32 papers, 710 citations indexed

About

Morteza Akbari is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Morteza Akbari has authored 32 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Morteza Akbari's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Morteza Akbari is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Morteza Akbari collaborates with scholars based in Iran, Iraq and Russia. Morteza Akbari's co-authors include Navid Shomali, Ahad Mokhtarzadeh, Behzad Baradaran, Lakshmi Thangavelu, Zohreh Jahanafrooz, Jafar Mosafer, Faroogh Marofi, Siamak Sandoghchian Shotorbani, XU Hua-xi and Milad Asadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Clinica Chimica Acta.

In The Last Decade

Morteza Akbari

31 papers receiving 699 citations

Peers

Morteza Akbari

ONCOL

IMMUN

Wencai Guan China

Xiaobing Jiang China

Han Yang China

Yingchi Zhang China

Chengyan Wang China

Ran Xie China

Ling Xi China

Zhaowei Gao China

Yueqi Wang China

Wencai Guan China

Morteza Akbari

356 ×1.0

118 ×0.5

ONCOL

226 ×1.1

81 ×0.7

IMMUN

60 ×0.9

Citations per year, relative to Morteza Akbari Morteza Akbari (= 1×) peers Wencai Guan

Countries citing papers authored by Morteza Akbari

Since Specialization

Citations

This map shows the geographic impact of Morteza Akbari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morteza Akbari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morteza Akbari more than expected).

Fields of papers citing papers by Morteza Akbari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morteza Akbari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morteza Akbari. The network helps show where Morteza Akbari may publish in the future.

Co-authorship network of co-authors of Morteza Akbari

This figure shows the co-authorship network connecting the top 25 collaborators of Morteza Akbari. A scholar is included among the top collaborators of Morteza Akbari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morteza Akbari. Morteza Akbari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akbari, Morteza, et al.. (2025). Micelleplex nucleic acid delivery systems: Overcoming barriers for treatment of advanced solid tumors. Materials & Design. 260. 115098–115098. 1 indexed citations

Akbari, Morteza, et al.. (2024). Paclitaxel for breast cancer therapy: A review on effective drug combination modalities and nano drug delivery platforms. Journal of Drug Delivery Science and Technology. 95. 105567–105567. 26 indexed citations

Behroozi, Javad, et al.. (2023). Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities. Molecular Biology Reports. 50(11). 9529–9543. 41 indexed citations

Adili, Ali, et al.. (2022). Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives. Pathology - Research and Practice. 236. 153982–153982. 4 indexed citations

Mohammed, Rebar N., Heshu Sulaiman Rahman, Ali Adili, et al.. (2022). Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Communication and Signaling. 20(1). 90–90. 1 indexed citations

Alesaeidi, ‬‬Samira, et al.. (2022). A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review. Cancer Cell International. 22(1). 269–269. 8 indexed citations

Zaman, Burhan Abdullah, et al.. (2022). SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis. Pathology - Research and Practice. 239. 154131–154131. 8 indexed citations

Mardi, Amirhossein, Rebar N. Mohammed, Ali Keshavarz, et al.. (2022). Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell International. 22(1). 168–168. 64 indexed citations

Mohammed, Rebar N., Heshu Sulaiman Rahman, Ali Adili, et al.. (2022). A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Communication and Signaling. 20(1). 79–79. 33 indexed citations

10.

Mikhailova, M. V., Lakshmi Thangavelu, Navid Shomali, et al.. (2022). Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Research & Therapy. 13(1). 423–423. 64 indexed citations

11.

Naghsh, Navid, et al.. (2022). A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview. Journal of Ovarian Research. 15(1). 81–81. 8 indexed citations

12.

Khosravi, Mohsen, Heshu Sulaiman Rahman, Ali Adili, et al.. (2022). Anastasis: cell recovery mechanisms and potential role in cancer. Cell Communication and Signaling. 20(1). 81–81. 18 indexed citations

13.

Mohammed, Rebar N., Heshu Sulaiman Rahman, Ali Adili, et al.. (2022). Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Communication and Signaling. 20(1). 139–139. 1 indexed citations

14.

Rahman, Heshu Sulaiman, Marwah Suliman Maashi, Svetlana Danshina, et al.. (2021). MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers. Genes & Diseases. 9(4). 849–867. 25 indexed citations

15.

Marofi, Faroogh, Heshu Sulaiman Rahman, Lakshmi Thangavelu, et al.. (2021). Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy. Stem Cell Research & Therapy. 12(1). 200–200. 38 indexed citations

16.

Hosseini, Leila, Marjan Erfani, Javad Mahmoudi, et al.. (2021). Effect of transcranial near-infrared photobiomodulation on cognitive outcomes in D-galactose/AlCl3 induced brain aging in BALB/c mice. Lasers in Medical Science. 37(3). 1787–1798. 11 indexed citations

17.

Shomali, Navid, Javad Mahmoudi, Ata Mahmoodpoor, et al.. (2020). Harmful effects of high amounts of glucose on the immune system: An updated review. Biotechnology and Applied Biochemistry. 68(2). 404–410. 35 indexed citations

18.

Nabipoorashrafi, Seyed Ali, Navid Shomali, Mahmoud Mahami‐Oskouei, et al.. (2020). miR‐143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life. 72(9). 2034–2044. 32 indexed citations

19.

Asadi, Milad, et al.. (2019). Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation. Journal of Cellular Physiology. 234(12). 21683–21693. 24 indexed citations

20.

Akbari, Morteza, Navid Shomali, Dariush Shanehbandi, et al.. (2019). CD133: An emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biology International. 44(2). 368–380. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact